Overview

Sector	Healthcare
Industry	-
Day Range	30.84 \| 31.46
52-Wk Range	21.75 \| 31.59
Last Close	31.24
Mkt Cap (m)	18,627.21
Dividend yield	1.1%
ISIN	ES0171996087
Volume	562,675
Exchange Venue	XMAD

Company Profile

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.

Key Information

Price/Earning	39.05
Price/Book	4.48
Price/Sales	4.33
P/CF	32.17
Rev Growth (3 year avg)	4.47
EPS Growth (3 year avg)	0.04
Operating Margin %	22.16
Net Margin %	13.30
Return on Equity	15.19
Debt/Equity	1.49

Legal Documents

Prospectus

en 23/04/2015

Annual Report

en 31/12/2018

Financials

Income Statement

EUR	2013	2014	2015	2016	2017	2018
Revenue (m)	2,742	3,355	3,935	4,050	4,318	4,487
Operating Income (m)	736	858	970	939	1,003	994
Net Income (m)	346	470	532	545	663	597
Basic EPS	0.51	0.69	0.78	0.80	0.97	0.87
Avg. Diluted Shares Outstanding (m)	681	685	686	684	684	685

Balance Sheet

EUR	2013	2014	2015	2016	2017	2018
Current Assets (m)	2,140	2,913	3,089	3,123	2,945	3,483
Non Current Assets (m)	3,701	5,537	6,512	7,007	7,975	8,994
Total Assets (m)	5,841	8,450	9,602	10,130	10,920	12,477
Current Liabilities (m)	715	1,080	1,053	1,072	978	1,257
Total Liabilities (m)	-	-	-	-	-	-
Total Equity (m)	2,101	2,658	3,296	3,721	3,629	4,226

Cash Flows

EUR	2013	2014	2015	2016	2017	2018
Operating Cash Flows (m)	592	979	743	553	842	737
Capital Expenditure (m)	-173	-287	-567	-293	-323	-308

Figures are quoted in EUR unless stated otherwise

0.00 (0.00%)

€

31.24

Last Price

Cookie Policy Privacy Notice Terms of Use Security Awareness